C9 | Complement component 9 | Disease related genes Plasma proteins Predicted secreted proteins
| ![](/images/29577/ihc_selected_60x60.jpg) | | ![](/images/2151/ihc_cell_selected_60x60.jpg) | ![](/images/2151/5802_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
BHMT | Betaine--homocysteine S-methyltransferase | Enzymes Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/38285/78554_B_8_2_rna_selected_60x60.jpg) | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/49793/141695_B_9_3_rna_selected_60x60.jpg) | Group enriched |
FGL1 | Fibrinogen-like 1 | Plasma proteins Predicted secreted proteins
| ![](/images/49320/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/49320/117061_B_7_2_rna_selected_60x60.jpg) | Group enriched |
PRODH2 | Proline dehydrogenase (oxidase) 2 | Enzymes
| ![](/images/51287/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/51287/120084_B_9_2_rna_selected_60x60.jpg) | Group enriched |
AFP | Alpha-fetoprotein | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/10607/25808_B_8_1_rna_selected_60x60.jpg) | Group enriched |
SLCO1B3 | Solute carrier organic anion transporter family, member 1B3 | Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | ![](/images_static/rna_center.gif) | ![](/images/4943/13415_A_2_2_rna_selected_60x60.jpg) | Tissue enriched |
MASP2 | Mannan-binding lectin serine peptidase 2 | Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| ![](/images/29313/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/29313/72651_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
OTC | Ornithine carbamoyltransferase | Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | ![](/images/243/ihc_cell_selected_60x60.jpg) | ![](/images/243/579_A_2_4_rna_selected_60x60.jpg) | Group enriched |
IGFALS | Insulin-like growth factor binding protein, acid labile subunit | Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/40948/92377_B_7_8_rna_selected_60x60.jpg) | Group enriched |
ATF5 | Activating transcription factor 5 | Transcription factors
| ![](/images/30187/ihc_selected_60x60.jpg) | | ![](/images/30187/ihc_cell_selected_60x60.jpg) | ![](/images/30187/62506_B_9_2_rna_selected_60x60.jpg) | Group enriched |
C19orf80 | Chromosome 19 open reading frame 80 | Plasma proteins Predicted secreted proteins
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enriched |
RGN | Regucalcin | Enzymes Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/29102/67318_B_9_3_rna_selected_60x60.jpg) | Group enriched |
PCK2 | Phosphoenolpyruvate carboxykinase 2 (mitochondrial) | Citric acid cycle related proteins Disease related genes Enzymes Mitochondrial proteins Plasma proteins Potential drug targets
| | | ![](/images/51162/ihc_cell_selected_60x60.jpg) | ![](/images/51162/124857_B_8_2_rna_selected_60x60.jpg) | Group enriched |
ALDH6A1 | Aldehyde dehydrogenase 6 family, member A1 | Disease related genes Enzymes Mitochondrial proteins Potential drug targets Predicted membrane proteins
| | | | ![](/images/29074/65842_A_2_6_rna_selected_60x60.jpg) | Group enriched |
CES1 | Carboxylesterase 1 | Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/12023/30143_B_7_4_rna_selected_60x60.jpg) | Group enriched |
A1CF | APOBEC1 complementation factor | | | | ![](/images_static/rna_center.gif) | ![](/images/44079/132428_B_8_7_rna_selected_60x60.jpg) | Tissue enhanced |
ABCC6 | ATP-binding cassette, sub-family C (CFTR/MRP), member 6 | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
AOX1 | Aldehyde oxidase 1 | Enzymes Plasma proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/40199/88099_A_2_5_rna_selected_60x60.jpg) | Tissue enhanced |
ASS1 | Argininosuccinate synthase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/20896/48102_B_2_1_rna_selected_60x60.jpg) | Tissue enhanced |
CBS | Cystathionine-beta-synthase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/1223/5627_B_8_1_rna_selected_60x60.jpg) | Tissue enhanced |
CTH | Cystathionase (cystathionine gamma-lyase) | Disease related genes Enzymes Potential drug targets
| | | ![](/images/23300/ihc_cell_selected_60x60.jpg) | ![](/images/21591/51666_B_9_7_rna_selected_60x60.jpg) | Tissue enhanced |
ERRFI1 | ERBB receptor feedback inhibitor 1 | | ![](/images/27206/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/27206/61460_A_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
EVA1A | Eva-1 homolog A (C. elegans) | Predicted membrane proteins
| ![](/images/8055/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/8055/24360_B_7_8_rna_selected_60x60.jpg) | Tissue enhanced |
GCH1 | GTP cyclohydrolase 1 | Disease related genes Enzymes Potential drug targets
| ![](/images/28612/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/28612/64077_B_7_7_rna_selected_60x60.jpg) | Tissue enhanced |
KYNU | Kynureninase | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | | ![](/images/31686/67663_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
METTL7B | Methyltransferase like 7B | Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/38644/80024_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |
PAH | Phenylalanine hydroxylase | Disease related genes Enzymes FDA approved drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/28407/59771_B_9_2_rna_selected_60x60.jpg) | Tissue enhanced |
PROX1 | Prospero homeobox 1 | Plasma proteins Transcription factors
| ![](/images_static/rna_center.gif) | | ![](/images_static/rna_center.gif) | ![](/images_static/na_center.gif) | Tissue enhanced |
PSAT1 | Phosphoserine aminotransferase 1 | Disease related genes Enzymes Plasma proteins Potential drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/40567/151878_A_4_6_rna_selected_60x60.jpg) | Tissue enhanced |
TSKU | Tsukushi, small leucine rich proteoglycan | Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/8164/22022_B_9_1_rna_selected_60x60.jpg) | Tissue enhanced |
ZIC1 | Zic family member 1 | Transcription factors
| | | ![](/images_static/rna_center.gif) | ![](/images/4098/15789_B_9_3_rna_selected_60x60.jpg) | Tissue enhanced |